Inflammation, demyelination, neurodegeneration and neuroprotection in the pathogenesis of multiple sclerosis
about
Regional white matter atrophy--based classification of multiple sclerosis in cross-sectional and longitudinal dataIsoprostanes and neuroprostanes as biomarkers of oxidative stress in neurodegenerative diseasesNormal Development and Function of T Cells in Proline Rich 7 (Prr7) Deficient MiceThalamus pathology in multiple sclerosis: from biology to clinical application.Immunological mechanism of action and clinical profile of disease-modifying treatments in multiple sclerosis.Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis.The effect of pulse methylprednisolone plus theophylline treatment on clinical, pulmonary and inflammatory markers in relapses of multiple sclerosisType I IFN promotes IL-10 production from T cells to suppress Th17 cells and Th17-associated autoimmune inflammationInhibition of NR2B-Containing N-methyl-D-Aspartate Receptors (NMDARs) in Experimental Autoimmune Encephalomyelitis, a Model of Multiple SclerosisToll-like receptor 4 participates in the myelin disruptions associated with chronic alcohol abuse.The development of patient-reported outcome indices for multiple sclerosis (PRIMUS).Relationship between cerebrospinal fluid biomarkers for inflammation, demyelination and neurodegeneration in acute optic neuritisTargeting VIP and PACAP receptor signalling: new therapeutic strategies in multiple sclerosis.Endogenous opioid inhibition of proliferation of T and B cell subpopulations in response to immunization for experimental autoimmune encephalomyelitis.Cortical atrophy in experimental autoimmune encephalomyelitis: in vivo imagingInvestigation of IL-21 gene polymorphisms (rs2221903, rs2055979) in cases with multiple sclerosis of Azerbaijan, Northwest Iran.CNS-specific therapy for ongoing EAE by silencing IL-17 pathway in astrocytesExcitotoxins, Mitochondrial and Redox Disturbances in Multiple Sclerosis.Silencing of Abcc8 or inhibition of newly upregulated Sur1-Trpm4 reduce inflammation and disease progression in experimental autoimmune encephalomyelitis.Therapeutic effect of baicalin on experimental autoimmune encephalomyelitis is mediated by SOCS3 regulatory pathway.Accelerated and enhanced effect of CCR5-transduced bone marrow neural stem cells on autoimmune encephalomyelitis.Epigenetic regulation of the expression of Il12 and Il23 and autoimmune inflammation by the deubiquitinase Trabid.CD 4+ T cells in the pathobiology of neurodegenerative disorders.Inhibition of TLR ligand- and interferon gamma-induced murine microglial activation by Panax notoginseng.Bladder dysfunction in mice with experimental autoimmune encephalomyelitis.Inferring metabolic networks using the Bayesian adaptive graphical lasso with informative priors.Prostaglandins in pathogenesis and treatment of multiple sclerosis.Immunopharmacological role of the leukotriene receptor antagonists and inhibitors of leukotrienes generating enzymes in multiple sclerosis.Management of lower urinary tract dysfunction in multiple sclerosis: a systematic review and Turkish consensus report.Treatment options for patients with multiple sclerosis who have a suboptimal response to interferon-β therapy.Pharmacology and clinical efficacy of dimethyl fumarate (BG-12) for treatment of relapsing-remitting multiple sclerosis.Fingolimod for multiple sclerosis: a review for the specialist nurse.A basic overview of multiple sclerosis immunopathology.Androstenediol Reduces Demyelination-Induced Axonopathy in the Rat Corpus Callosum: Impact on Microglial Polarization.Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe's disease.Synapsin-induced proliferation of T-cell lines against myelin basic protein obtained from rats with experimental autoimmune encephalomyelitis.IL-17 induces MIP-1α expression in primary mouse astrocytes via TRPC channel.Recent Advances on the Possible Neuroprotective Activities of Epstein-Barr Virus Oncogene BARF1 Protein in Chronic Inflammatory Disorders of Central Nervous System.Immunity and inflammation in neurodegenerative diseases.Increased risk of ischaemic stroke among patients with multiple sclerosis.
P2860
Q24647968-1ECCDDC6-6EDA-455F-9EC3-CB2792C36793Q26822872-CC394BEF-0CD5-4101-8C8B-6CE86ECC014BQ27322365-68DD4C71-9BD0-4650-AC36-B53FAB2ED894Q30871067-681E338A-7B7A-42A1-99BE-2E47F8DCE39CQ33755345-0C9FA2EF-1857-450E-A8EE-E4E697214668Q33810559-74D26BC6-C1D7-4B1D-9A70-AA3026811A6EQ33974404-03E7F82E-711A-4F54-B0A9-46BFB940B345Q34097852-E1287492-B331-4328-A917-6FD36478FB38Q34146191-81E4157E-22F8-4AE9-900D-DE0A4396B5B5Q34262386-686E9959-5665-4601-AA37-5402B6EE56EAQ34989085-42558346-6623-4868-929B-9F4DA3DC29BDQ35015106-18630AC8-A5B5-4BB7-B4ED-3E4029DF6219Q35295564-675AA51B-B123-4412-8C1D-FDED402AEA38Q35532019-8CBDA285-F097-4E64-900B-009F205D550AQ35800453-88C06BAD-E101-403C-AA8F-5D5339A5F2FFQ35826376-80BCC716-D482-4C94-881C-106F4B8317B8Q36085387-D1B64B03-7FE3-4B89-934F-2CA8852FA42CQ36283207-9042111C-1DD9-4D44-9D15-AF38B94A185EQ36298402-526376F0-DF86-4C1F-A352-8D5726B7BAC7Q36330492-2DC86ECB-8DCC-4DB6-801D-5D7DC97CFC5CQ36530295-B744EDB9-B90C-4E6F-881E-86A5BAE33366Q36586330-23A08A10-5CBC-47A9-86D3-406033398869Q37228055-717925DB-3454-4262-9316-B2A42137C597Q37354222-258C29F8-D1CD-4996-9438-46CC9B07344CQ37384699-8A8CD0AC-1029-4583-8CEA-CAFBAE739663Q37579999-652CC161-4757-4733-BE81-0D8648F5EBDDQ37710103-23299C1B-705F-44EF-BC8D-B3D85878F638Q37713745-6DE04B30-3C4A-4107-AC1F-BAE1E046C276Q38113739-73492331-6497-469A-B468-82FAF7C430F0Q38163046-9660AC9F-9EC2-4FF9-9A39-344360713A2EQ38202636-DBC8433A-72F6-4C5E-8EDE-6961726DEDDEQ38220605-EADA2273-AA20-482C-A7EA-7B9431643EEDQ38587668-3D7CAABE-7558-4AB5-B256-784E51FF04ECQ38915955-FD8EF045-8621-4CF4-BAE5-E710649C1C20Q38957246-3CC9D7EC-AE1B-47AB-97A1-9D4148B47EE3Q39779675-A4DD43C9-F781-4485-8E01-573A771B82FDQ40091331-57A70F04-C020-47E3-A551-EE729D057797Q41136819-3622FBBF-D669-4B70-9C2F-C331EB97273FQ43104143-13FC1C75-1CB9-4514-867E-98023A29A32FQ43696444-98B11957-4C53-4B2D-8A7B-FB253F01BE37
P2860
Inflammation, demyelination, neurodegeneration and neuroprotection in the pathogenesis of multiple sclerosis
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Inflammation, demyelination, n ...... ogenesis of multiple sclerosis
@ast
Inflammation, demyelination, n ...... ogenesis of multiple sclerosis
@en
type
label
Inflammation, demyelination, n ...... ogenesis of multiple sclerosis
@ast
Inflammation, demyelination, n ...... ogenesis of multiple sclerosis
@en
prefLabel
Inflammation, demyelination, n ...... ogenesis of multiple sclerosis
@ast
Inflammation, demyelination, n ...... ogenesis of multiple sclerosis
@en
P2860
P1476
Inflammation, demyelination, n ...... ogenesis of multiple sclerosis
@en
P2093
Lisa K Peterson
Robert S Fujinami
P2860
P356
10.1016/J.JNEUROIM.2006.11.015
P577
2006-12-28T00:00:00Z